Tetra Pharm Technologies ApS — Credit Rating and Financial Key Figures
CVR number: 40738223
Søndre Jernbanevej 11, 3400 Hillerød
contact@tetrapharm.eu
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | - 926.10 | 3 208.29 | 584.76 | 1 460.64 | |
| Costs of management | -12 871.24 | -15 785.76 | -32 770.02 | ||
| Costs of distribution | -8 067.08 | -23 615.71 | -29 696.68 | ||
| Employee benefit expenses | - 146.33 | -3 534.92 | |||
| Total depreciation | -72.52 | -87.60 | -2 319.91 | -3 898.19 | |
| EBIT | -1 144.96 | - 414.24 | -20 938.32 | -38 816.71 | -61 006.07 |
| Other financial income | 0.03 | 422.78 | 159.95 | ||
| Other financial expenses | -6.11 | -87.64 | -58.52 | -6.94 | -19.95 |
| Pre-tax profit | -1 151.07 | - 501.87 | -20 996.81 | -38 400.87 | -60 866.06 |
| Income taxes | 253.22 | 807.47 | 1 432.64 | 5 454.00 | 5 652.35 |
| Net earnings | - 897.85 | 305.59 | -19 564.18 | -32 946.87 | -55 213.71 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Development expenditure | 3 168.39 | ||||
| Intangible assets total | 3 168.39 | ||||
| Buildings | 221.01 | 580.01 | 3 583.91 | 14 174.62 | 15 157.60 |
| Machinery and equipment | 116.71 | 138.96 | |||
| Tangible assets total | 337.72 | 718.97 | 3 583.91 | 14 174.62 | 15 157.60 |
| Investments total | 138.00 | 922.31 | 916.33 | 1 133.14 | 2 069.49 |
| Non-current other receivables | 3 859.28 | ||||
| Long term receivables total | 3 859.28 | ||||
| Semifinished products | 3 048.97 | ||||
| Inventories total | 3 048.97 | ||||
| Current trade debtors | 1 180.01 | ||||
| Prepayments and accrued income | 63.83 | ||||
| Current other receivables | 119.37 | 311.22 | 1 213.59 | 2 739.96 | 3 494.08 |
| Current deferred tax assets | 253.22 | 1 060.69 | 2 150.21 | 7 604.21 | 5 500.00 |
| Short term receivables total | 436.42 | 1 371.90 | 3 363.79 | 10 344.17 | 10 174.09 |
| Cash and bank deposits | 5 198.40 | 60 916.54 | 8 927.62 | 3 876.44 | |
| Cash and cash equivalents | 5 198.40 | 60 916.54 | 8 927.62 | 3 876.44 | |
| Balance sheet total (assets) | 912.14 | 18 288.23 | 68 780.58 | 34 579.55 | 31 277.63 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 48.08 | 62.39 | 62.39 | 67.59 |
| Share premium account | 1.65 | 15 027.86 | 90 009.59 | 90 009.59 | 139 875.60 |
| Other reserves | 2 471.36 | ||||
| Retained earnings | -4 066.24 | -5 473.13 | -25 037.30 | -57 984.17 | |
| Profit of the financial year | - 897.85 | 305.59 | -19 564.18 | -32 946.87 | -55 213.71 |
| Shareholders equity total | - 856.20 | 13 786.65 | 65 034.68 | 32 087.81 | 26 745.31 |
| Provisions | 697.03 | ||||
| Non-current trade creditors | 28.26 | 194.89 | |||
| Non-current owed to group member | 2 637.63 | ||||
| Non-current other liabilities | 1 356.80 | ||||
| Non-current deferred tax liabilities | 972.04 | ||||
| Non-current liabilities total | 1 385.06 | 3 804.55 | |||
| Current loans from credit institutions | 383.27 | ||||
| Current trade creditors | 2 478.03 | 1 332.20 | 3 238.89 | ||
| Current owed to participating | 1 321.12 | ||||
| Other non-interest bearing current liabilities | -1 321.12 | 1 267.87 | 1 159.53 | 1 293.42 | |
| Current liabilities total | 383.27 | 3 745.90 | 2 491.73 | 4 532.31 | |
| Balance sheet total (liabilities) | 912.14 | 18 288.23 | 68 780.58 | 34 579.55 | 31 277.63 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.